Track the 佐力药业 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 佐力药业 has published 3 public disclosures. Market capitalisation: €10bn. The latest transaction was filed on 22 April 2024 (Sale). Among the most active insiders: 陆秀梅. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Zalijia Pharmaceutical 是一家在XSHE市场上市的健康和制药公司。它专注于创新药物的开发和生产。